Press Releases

09.22.2015

New Centrum® VitaMints® Offer a Refreshingly New Way to Take a Multivitamin

09.21.2015

Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis

09.18.2015

Pfizer Inc. Announces Results of Early Tenders and Consents in Exchange Offers

09.16.2015

Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts

09.11.2015

Merck KGaA, Darmstadt, Germany and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015

09.09.2015

Evotec enters into licence and collaboration agreement with Pfizer Inc. in tissue fibrosis

09.09.2015

GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members

09.09.2015

GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members

09.09.2015

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention

09.07.2015

AMRA announces collaboration with Pfizer to use imaging to potentially help identify those most at risk from metabolic disease and comorbidities

09.03.2015

Pfizer Inc. Commences Exchange Offers for Hospira Notes

08.26.2015

Alliance Foundation Trials and Austrian Breast & Colorectal Cancer Study Group Open Largest Global Phase 3 Trial of Targeted Therapy, IBRANCE® (palbociclib), for Patients with Hormone Receptor–Positive Early Breast Cancer